203 related articles for article (PubMed ID: 35349196)
1. Enlightening the "Spirit Molecule": Photomodulation of the 5-HT
Gerwe H; He F; Pottie E; Stove C; Decker M
Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202203034. PubMed ID: 35349196
[TBL] [Abstract][Full Text] [Related]
2. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
Smith RL; Canton H; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
[TBL] [Abstract][Full Text] [Related]
3. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
4. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
5. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
Cameron LP; Olson DE
ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
[TBL] [Abstract][Full Text] [Related]
6. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
[TBL] [Abstract][Full Text] [Related]
7. Possible psychedelic therapeutic mechanism.
Hess EM; Gould TD
Science; 2023 Feb; 379(6633):642-643. PubMed ID: 36795807
[TBL] [Abstract][Full Text] [Related]
8. Identification of 5-HT
Wallach J; Cao AB; Calkins MM; Heim AJ; Lanham JK; Bonniwell EM; Hennessey JJ; Bock HA; Anderson EI; Sherwood AM; Morris H; de Klein R; Klein AK; Cuccurazzu B; Gamrat J; Fannana T; Zauhar R; Halberstadt AL; McCorvy JD
Nat Commun; 2023 Dec; 14(1):8221. PubMed ID: 38102107
[TBL] [Abstract][Full Text] [Related]
9. Photoswitchable Serotonins for Optical Control of the 5-HT
Morstein J; Romano G; Hetzler BE; Plante A; Haake C; Levitz J; Trauner D
Angew Chem Int Ed Engl; 2022 Apr; 61(18):e202117094. PubMed ID: 34989082
[TBL] [Abstract][Full Text] [Related]
10. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT
Riga MS; Lladó-Pelfort L; Artigas F; Celada P
Neuropharmacology; 2018 Nov; 142():219-230. PubMed ID: 29221792
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
12. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
[TBL] [Abstract][Full Text] [Related]
13. Human brain effects of DMT assessed via EEG-fMRI.
Timmermann C; Roseman L; Haridas S; Rosas FE; Luan L; Kettner H; Martell J; Erritzoe D; Tagliazucchi E; Pallavicini C; Girn M; Alamia A; Leech R; Nutt DJ; Carhart-Harris RL
Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2218949120. PubMed ID: 36940333
[TBL] [Abstract][Full Text] [Related]
14. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.
Fontanilla D; Johannessen M; Hajipour AR; Cozzi NV; Jackson MB; Ruoho AE
Science; 2009 Feb; 323(5916):934-7. PubMed ID: 19213917
[TBL] [Abstract][Full Text] [Related]
15. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
Frecska E; Szabo A; Winkelman MJ; Luna LE; McKenna DJ
J Neural Transm (Vienna); 2013 Sep; 120(9):1295-303. PubMed ID: 23619992
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of cerebral metabolism and serotonin 5-HT
Egger K; Gudmundsen F; Jessen NS; Baun C; Poetzsch SN; Shalgunov V; Herth MM; Quednow BB; Martin-Soelch C; Dornbierer D; Scheidegger M; Cumming P; Palner M
Front Pharmacol; 2023; 14():1140656. PubMed ID: 37841918
[No Abstract] [Full Text] [Related]
17. 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.
Rabin RA; Regina M; Doat M; Winter JC
Pharmacol Biochem Behav; 2002 May; 72(1-2):29-37. PubMed ID: 11900766
[TBL] [Abstract][Full Text] [Related]
18. Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT
Pottie E; Poulie CBM; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Kristensen JL; Stove CP
ACS Chem Neurosci; 2023 Aug; 14(15):2727-2742. PubMed ID: 37474114
[TBL] [Abstract][Full Text] [Related]
19. Chemistry and Structure-Activity Relationships of Psychedelics.
Nichols DE
Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524
[TBL] [Abstract][Full Text] [Related]
20. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
